Results 121 to 130 of about 3,675 (177)

Hybrid nanocarriers incorporating mechanistically distinct drugs for lymphatic CD4+ T cell activation and HIV-1 latency reversal. [PDF]

open access: yesSci Adv, 2019
Cao S   +10 more
europepmc   +1 more source

Rapamycin-mediated mTOR inhibition uncouples HIV-1 latency reversal from cytokine-associated toxicity. [PDF]

open access: yesJ Clin Invest, 2017
Martin AR   +5 more
europepmc   +1 more source

Integration site-independent enhancement of latency reversal by HIV-1 Nef

open access: yesJournal of Virus Eradication, 2017
X.T. Kuang   +3 more
openaire   +2 more sources

Novel use of alprazolam as a potential HIV-1 latency reversing agent

open access: yesJournal of Virus Eradication, 2017
W. Elbezanti   +4 more
openaire   +2 more sources

O3 Heme-arginate as a latency-reversing agent for HIV-1 cure

open access: yesJournal of Virus Eradication, 2017
Michaela Madlenakova   +6 more
openaire   +2 more sources

Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator Systems. [PDF]

open access: yesPLoS One, 2016
Bialek JK   +7 more
europepmc   +1 more source

Kinetics of HIV-1 Latency Reversal Quantified on the Single-Cell Level Using a Novel Flow-Based Technique. [PDF]

open access: yesJ Virol, 2016
Martrus G   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy